Clin2
NCT07431606Possibly a fitRecruiting

Duloxetine for Inflammatory Bowel Disease

Inflammatory Bowel Diseases

Treatments studied

Part of Digestive system clinical trials.

This study tests whether duloxetine, a medication used for pain and mood, can help people with inflammatory bowel disease (IBD) who are also dealing with high stress, disability, or gut-related anxiety.

Summary written for real people, not researchers, by Clin2.

Phase
Phase 2
Enrollment
32 people
Ages
24 years and older
Study type
Interventional

Who can take part

  • You must be 25 years or older.
  • You must have IBD and be experiencing high stress, moderate-to-severe disability, or significant anxiety about your gut symptoms.
  • You cannot be currently taking any antidepressants, certain pain or mood medications, or specific antibiotics.
  • You cannot have started talk therapy in the last 8 weeks.
  • You must be willing to check your blood pressure at home and receive a monitor by mail.
  • You cannot have severe liver or kidney problems, glaucoma, or certain stomach conditions.

View the official record on ClinicalTrials.gov

Quick eligibility check

Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.

Similar studies

Other trials that look related to this one.

NCT07175454Not yet recruiting
Anxiety and depression in people with Crohn's disease or ulcerative colitis

This study looks at how anxiety and depression affect people living with inflammatory bowel disease (IBD), such as Crohn's disease or ulcerative colitis. It aims to understand these connections to improve care and support for patients.

Wolverhampton
NCT06342011Recruiting
Anti-inflammatory diet for inflammatory bowel disease

This trial tests whether an anti-inflammatory diet can help people with inflammatory bowel disease (IBD). Researchers want to see if this diet reduces inflammation and improves symptoms.

Yiwu, Zhejiang
NCT05185609Recruiting
Tests anal function in people with inflammatory bowel disease

This study checks how well the anal area works in people with inflammatory bowel disease (IBD), even when your bowel disease is “in remission” but you may still have symptoms. It may help doctors better understand the cause of ongoing problems and guide future care.

Örebro
NCT07590518Not yet recruiting
Virtual reality therapy for inflammatory bowel disease and anxiety

This study tests whether virtual reality (VR) therapy can help reduce anxiety in people with inflammatory bowel disease (IBD). You'll use a VR headset at home to do guided exercises, which may help you feel calmer and better manage your condition.

Los Angeles, California
NCT07168499Recruiting
Diet, stress, and advanced therapy for Crohn's and colitis

This study tests whether adding a diet and stress management program to standard advanced therapy helps people with active Crohn's disease or ulcerative colitis feel better. It combines lifestyle changes with new medications to improve treatment outcomes.

Boston, Massachusetts
NCT07556718Recruiting· Phase 2
Amitriptyline for IBS-like Symptoms in Stable Crohn's Disease

This study tests whether a medication called amitriptyline can help reduce belly pain and bowel problems in people whose Crohn's disease is well-controlled. Amitriptyline is an older antidepressant that may help with pain and bowel symptoms even when inflammation is quiet.

Ann Arbor, Michigan

Hear when a new Inflammatory Bowel Diseases trial opens

We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.